JOURNAL OF DIABETES AND ITS COMPLICATIONS, cilt.35, sa.12, 2021 (SCI-Expanded)
Objectives: Osteoprotegerin (OPG), a well-known protein that inhibits osteoclast formation and activity, might also be a potential marker for identifying patients with high cardiovascular risk. This study aimed to compare OPG levels, FMD, and CIMT measurements in subjects with vs. without diabetes and investigate the association of serum osteoprotegerin level with the early atherosclerotic markers, endothelial function, and carotid intimamedia thickness (CIMT) in patients with type 2 diabetes mellitus (DM2).